Trademark: 88160368
Status Date
Monday, June 13, 2022
Filing Date
Thursday, October 18, 2018
Published for Opposition
Tuesday, March 12, 2019
Abandoned Date
Monday, June 13, 2022
5 pharmaceutical preparations and substances for the treatment of oncological, autoimmune and central nervous system diseases and disorders
Jun 13, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jun 13, 2022
Abandonment - No Use Statement Filed
Nov 6, 2021
Notice Of Approval Of Extension Request E-Mailed
Nov 5, 2021
Sou Extension 5 Granted
Nov 1, 2021
Sou Extension 5 Filed
Nov 1, 2021
Teas Extension Received
May 6, 2021
Notice Of Approval Of Extension Request E-Mailed
May 4, 2021
Sou Extension 4 Granted
May 4, 2021
Sou Extension 4 Filed
May 4, 2021
Teas Extension Received
Feb 11, 2021
Notice Of Approval Of Extension Request E-Mailed
Feb 10, 2021
Sou Extension 3 Granted
Nov 9, 2020
Sou Extension 3 Filed
Feb 9, 2021
Case Assigned To Intent To Use Paralegal
Nov 11, 2020
Notice Of Revival - E-Mailed
Nov 11, 2020
Extension Received With Teas Petition
Nov 11, 2020
Petition To Revive-Granted
Nov 11, 2020
Teas Petition To Revive Received
May 7, 2020
Notice Of Approval Of Extension Request E-Mailed
May 5, 2020
Sou Extension 2 Granted
May 5, 2020
Sou Extension 2 Filed
May 5, 2020
Teas Extension Received
Nov 7, 2019
Notice Of Approval Of Extension Request E-Mailed
Nov 5, 2019
Sou Extension 1 Granted
Nov 5, 2019
Sou Extension 1 Filed
Nov 5, 2019
Teas Extension Received
May 7, 2019
Noa E-Mailed - Sou Required From Applicant
Mar 12, 2019
Official Gazette Publication Confirmation E-Mailed
Mar 12, 2019
Published For Opposition
Feb 20, 2019
Notification Of Notice Of Publication E-Mailed
Jan 28, 2019
Approved For Pub - Principal Register
Jan 28, 2019
Assigned To Examiner
Oct 31, 2018
New Application Office Supplied Data Entered
Oct 22, 2018
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24